Neurocrine Biosciences Inc (NBIX) — Capital Reinvestment Ratio
Neurocrine Biosciences Inc (NBIX) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow ($388.40 Million) in capital expenditures ($2.40 Million). See Neurocrine Biosciences Inc (NBIX) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Neurocrine Biosciences Inc Capital Reinvestment Ratio (1996–2025)
This chart tracks Neurocrine Biosciences Inc's Capital Reinvestment Ratio across 12 annual periods. Check Neurocrine Biosciences Inc (NBIX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Neurocrine Biosciences Inc (1996–2025)
Year-by-year Capital Reinvestment Ratio for Neurocrine Biosciences Inc from 1996 to 2025. For live market cap and broader valuation context, see Neurocrine Biosciences Inc (NBIX) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $782.70 Million | $34.00 Million | ▼ -32.3% |
| 2024 | 0.06x | $595.40 Million | $38.20 Million | ▼ -11.6% |
| 2023 | 0.07x | $389.90 Million | $28.30 Million | ▲ +49.3% |
| 2022 | 0.05x | $339.40 Million | $16.50 Million | ▼ -46.7% |
| 2021 | 0.09x | $256.50 Million | $23.40 Million | ▲ +91.2% |
| 2020 | 0.05x | $228.50 Million | $10.90 Million | ▼ -52.3% |
| 2019 | 0.10x | $147.00 Million | $14.70 Million | ▼ -59.1% |
| 2018 | 0.24x | $101.40 Million | $24.80 Million | ▲ +3777.7% |
| 2010 | 0.01x | $49.94 Million | $315.00K | ▼ -99.5% |
| 2003 | 1.36x | $37.13 Million | $50.44 Million | ▲ +133.5% |
| 1997 | 0.58x | $11.00 Million | $6.40 Million | ▲ +143.6% |
| 1996 | 0.24x | $6.70 Million | $1.60 Million | — |